Indrayani Biotech Ltd

Indrayani Biotech Ltd

₹ 15.5 -2.70%
04 Jul - close price
About

Incorporated in 1992, Indrayani Biotech
Ltd is in the business of Foods & Hospitality, Engineering and Healthcare[1]

Key Points

Business Overview:[1]
IBL has multiple business units managed by an
independent team of field experts. It operates
in Food and Hospitality, Dairy, Healthcare & Pharma, Engineering, Biotech, Agriculture and Infrastructure

  • Market Cap 70.5 Cr.
  • Current Price 15.5
  • High / Low 60.5 / 13.0
  • Stock P/E
  • Book Value 15.9
  • Dividend Yield 0.00 %
  • ROCE 2.82 %
  • ROE -6.47 %
  • Face Value 10.0

Pros

  • Stock is trading at 0.97 times its book value

Cons

  • Company has low interest coverage ratio.
  • Promoter holding is low: 33.3%
  • Company has a low return on equity of 6.77% over last 3 years.
  • Earnings include an other income of Rs.3.13 Cr.
  • Company has high debtors of 164 days.
  • Promoter holding has decreased over last 3 years: -15.5%
  • Working capital days have increased from 238 days to 412 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
17.25 25.63 42.05 46.00 49.25 42.31 40.44 39.09 44.38 31.53 30.81 17.32 50.57
15.02 22.60 36.85 40.67 46.07 39.77 33.15 35.64 34.21 27.55 25.70 14.40 56.31
Operating Profit 2.23 3.03 5.20 5.33 3.18 2.54 7.29 3.45 10.17 3.98 5.11 2.92 -5.74
OPM % 12.93% 11.82% 12.37% 11.59% 6.46% 6.00% 18.03% 8.83% 22.92% 12.62% 16.59% 16.86% -11.35%
0.01 0.39 1.96 0.08 2.05 0.01 0.09 0.08 1.03 0.04 0.30 0.00 2.78
Interest 0.44 0.97 1.15 1.21 2.23 2.03 0.93 1.41 5.51 2.25 1.42 1.03 7.07
Depreciation 0.18 0.66 0.75 0.78 1.15 0.90 0.91 1.03 0.96 0.83 2.79 1.46 -1.72
Profit before tax 1.62 1.79 5.26 3.42 1.85 -0.38 5.54 1.09 4.73 0.94 1.20 0.43 -8.31
Tax % 0.62% 0.00% 0.00% -0.88% 21.62% 15.79% 0.00% 0.00% 0.00% 9.57% -1.67% 18.60% 2.53%
1.61 1.79 5.26 3.44 1.44 -0.45 5.54 1.08 4.73 0.85 1.21 0.35 -8.52
EPS in Rs 0.44 0.52 1.54 0.72 0.32 -0.13 1.62 0.22 0.85 0.19 0.13 0.05 -1.28
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2010 Mar 2011 Mar 2012 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0 39 58 50 21 61 163 165 130
0 39 57 47 26 54 145 142 124
Operating Profit -0 1 1 3 -5 7 17 24 6
OPM % -105% 2% 1% 6% -24% 11% 11% 14% 5%
0 0 0 0 -4 0 4 1 3
Interest 0 0 0 1 2 2 6 10 12
Depreciation 0 0 0 1 0 1 3 4 3
Profit before tax -0 0 0 1 -11 4 12 11 -6
Tax % 0% 150% 300% 0% 0% 0% 3% 5% 6%
-0 -0 -0 1 -11 4 12 10 -6
EPS in Rs -0.14 -0.16 2.22 -3.28 1.30 2.55 1.40 -0.99
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 21%
3 Years: 29%
TTM: -21%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -171%
Stock Price CAGR
10 Years: %
5 Years: 12%
3 Years: -24%
1 Year: -73%
Return on Equity
10 Years: %
5 Years: 4%
3 Years: 7%
Last Year: -6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2010 Mar 2011 Mar 2012 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 6 4 4 4 34 34 34 46 46
Reserves -6 -0 -0 27 -15 -10 12 22 27
0 0 0 14 16 19 79 113 137
1 6 9 7 5 8 31 54 59
Total Liabilities 1 10 12 51 40 51 156 234 268
1 6 6 17 15 17 57 62 58
CWIP -0 0 0 14 14 13 14 20 26
Investments 0 0 0 0 0 0 0 0 0
0 4 7 21 11 22 85 151 185
Total Assets 1 10 12 51 40 51 156 234 268

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2010 Mar 2011 Mar 2012 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1 2 6 0 4 16 -30 -7
-3 -0 -4 -1 -1 -47 -16 25
2 -1 -1 -0 -3 33 44 -18
Net Cash Flow 0 1 1 -1 1 2 -2 -0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2010 Mar 2011 Mar 2012 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 0 26 26 52 84 84 67 87 164
Inventory Days 365 57 25 14 44 159 182
Days Payable 365 70 77 52 81 141 104
Cash Conversion Cycle 0 26 26 38 32 46 30 106 243
Working Capital Days -1,883 -1 -8 80 71 56 83 219 412
ROCE % 28% 12% -13% 16% 23% 14% 3%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
44.91% 44.89% 44.89% 44.89% 44.89% 44.84% 33.63% 33.57% 33.48% 33.40% 33.28% 33.28%
22.04% 19.17% 17.16% 17.02% 15.27% 13.11% 7.58% 6.75% 4.07% 5.59% 5.25% 3.66%
33.05% 35.94% 37.96% 38.09% 39.84% 42.05% 58.78% 59.68% 62.46% 61.01% 61.49% 63.07%
No. of Shareholders 20,91422,04922,11221,91922,43522,59023,03423,95824,13224,41925,25425,126

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents